Identification of a Colorectal Tumor-Associated Antigen (COA-1) Recognized by CD4+ T Lymphocytes

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6735-6743

  Maccalli, Cristina ^b   Li, Yong F ^a   El Gamil, Mona ^a   Rosenberg, Steven A ^a   Robbins, Paul F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD4 ANTIGEN; HLA DR ANTIGEN; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ARTICLE; CANCER PATIENT; COLORECTAL TUMOR; DNA LIBRARY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR CLONING; MOLECULAR RECOGNITION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; TUMOR ASSOCIATED LEUKOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EPITOPES, T-LYMPHOCYTE; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0142219890     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. DeCosse, J. J., Tsioulias, G. J., and Jacobson, J. S. Colorectal cancer: detection, treatment, and rehabilitation. CA Cancer J. Clin., 44: 27-42, 1994.
2. Harrington, D. P. The tea leaves of small trials. J. Clin. Oncol., 17: 1336-1338, 1999.
3. Rosenberg, S. A., Packard, B. S., Acbersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D., Wei, J. P., and White, D. E. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med., 319: 1676-1680, 1988.
4. Mukherji, B., and Chakraborty, N. G. Immunobiology and immunotherapy of melanoma. Curr. Opin. Oncol., 7: 175-184, 1995.
5. Riethmuller, G., Holz, E., Schlimok, G., Schmiegel, W., Raab, R., Hoffken, K., Gruber, R., Funke, I., Pichlmaier, H., Hirche, H., Buggisch, P., Witte, J., and Pichlmayr, R. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J. Clin. Oncol., 16: 1788-1794, 1998.
6. Vermorken, J. B., Claessen, A. M., van Tinteren, H., Gall, H. E., Ezinga, R., Meijer, S., Scheper, R. J., Meijer, C. J., Bloemena, E., Ransom, J. H., Hanna, M. G., Jr., and Pinedo. H. M. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet, 353: 345-350, 1999.
7. Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigcnji, K., Nagura, H., and Ohtani, H. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res., 58: 3491-3494, 1998.
8. Browning, M., Petronzelli, F., Bicknell, D., Krausa, P., Rowan, A., Tonks, S., Murray, N., Bodmer, J., and Bodmer, W. Mechanisms of loss of HLA class 1 expression on colorectal tumor cells. Tissue Antigens, 47: 364-371, 1996.
9. Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., and Stern, P. L. Natural history of HLA expression during tumour development. Immunol. Today, 14: 491-499, 1993.
10. Coulie, P. G., Ikeda, H., Baurain, J. F., and Chiari, R. Antitumor immunity at work in a melanoma patient. Adv. Cancer Res., 76: 213-242, 1999.
11. Renkvist N., Castelli, C., Robbins, P. F., and Parmiani, G. A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother., 50: 3-15, 2001.
12. Tsang, K. Y., Zhu, M., Nieroda, C. A., Correale, P., Zaremba, S., Hamilton, J. M., Cole, D., Lam, C., and Schlom, J. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. Clin. Cancer Res., 3: 2439-2449, 1997.
13. Akagi, J., Nakagawa, K., Egami, H., and Ogawa, M. Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-I vaccinia virus. Cancer Immunol. Immunother., 47: 21-31, 1998.
14. Brossart, P., Stuhler, G., Flad, T., Stevanovic, S., Rammensee, H. G., Kanz, L., and Brugger, W. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res., 58: 732-736, 1998.
15. Ito, M., Shichijo, S., Tsuda, N., Ochi, M., Harashima, N., Salto, N., and Itoh, K. Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res., 61: 2038-2046, 2001.
16. Lapointe, R., Lemieux, R., Olivier, M., and Darvcau, A. Tyrosine kinase and cAMP-dependent protein kinase activities in CD40-activated human B lymphocytes. Eur. J. Immunol., 26: 2376-2382, 1996.
17. Robbins, P. F., El-Gamil, M., Li, Y. F., Zeng, G., Dudley, M., and Rosenberg, S. A. Multiple HLA class 11-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J. Immunol. 169: 6036-6047, 2002.
18. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
19. Lopez-Concjo, T., Olmo, N., Turnay, J., Navarro, J., and Lizarbe, A. Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line. Int. J. Cancer, 67: 668-675, 1996.
20. Katoh, H., Harada, A., Mori, K., and Negishi, M. Socius is a novel Rnd GTPase-interacting protein involved in disassembly of actin stress fibers. Mol. Cell. Biol., 22: 2952-2964, 2002.
21. Wang, R. F., Wang, X., Atwood, A. C., Topalian, S. L., and Rosenberg, S. A. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor anltgen. Science (Wash. DC), 284: 1351-1354, 1999.
22. Rammensee, H., Bachmann, J., Emmcrich, N. P., Bachor, O. A., and Stevanovic, S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics, 50: 213-219, 1999.
23. Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., and Robbins, P. F. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med., 183: 1965-1971, 1996.
24. Morel, S., Levy, F., Burlet-Schiltz, O., Brasseur F., Probst-Kepper, M., Peitrequin, A. L., Monsarrat, B., Van Velthoven, R., Cerottini, J. C., Boon, T., Gairin, J. E., and Van den Eynde, B. J. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12: 107-117, 2000.
25. Doherty, D. G., Penzotti, J. E., Koelle, D. M., Kwok, W. W., Lybrand, T. P., Masewicz, S., and Nepom, G. T. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between, the T cell receptor, peptide, and HLA-DR. J. Immunol., 161: 3527-3535, 1998.
26. Di Giorgio, A., Botti, c., Toechi A., Mingazzini, P., and Flammia, M. The influence of tumor lymphocyte infiltration on long term survival of surgically treated colrectal cancer patients. Int. Surg., 77: 256-260, 1992.
27. Kinihiro, M., Tanaka, S., Haruma, K., Yoshihara, M., Sumii, K., Kajiyama, G., and Shimamoto, F. Combined expression of HLA-DR antigen and proliferating cell nuclear antigen correlate with colorectal cancer prognosis. Oncology, 55: 326-333, 1998.
28. Ransom, J. H., Pelle, B., and Hanna, M. G., Jr. Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy. Cancer Res., 52: 3460-3466, 1992.
29. Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., and Itoh, K. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res., 59: 4056-4063, 1999.
30. Bremers, A. H. A., Andreola, S., Leo, E., Gallino, F., Rini, F., Lombardo, C., Belli, F., Kuppen, P. J. K., Parmiani, G., and Castelli, C. T cell responses in colorectal cancer patients: evidence for class-II HLA restricted recognition of shared tumor-associated antigens. Int. J. Cancer, 88: 956-961, 2000.
31. Sacterdal, I., Bjorheim, J., Lislerud, K., Gjertsen, M. K., Bukholm, I. K., Olsen, O. C., Nesland, J. M., Eriksen, J. A., Moller, M., Lindblom, A., and Gaudernack, G. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc. Natl. Acad. Sci. USA, 98: 13255-13260, 2001.